Company Neuropathix, Inc.
Equities
NPTX
US64132Q1094
Biotechnology & Medical Research
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 18-07-24 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-07-24 |
Robert Malasek
BRD | Director/Board Member | 55 | 17-06-19 |
Mark McDonnell
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 17-06-19 |
Timothy Scott
BRD | Director/Board Member | 71 | 18-07-24 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
Blake Schroeder
BRD | Director/Board Member | 48 | 18-07-24 |
Thomas Kikis
FOU | Founder | 46 | 18-07-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 93,810,559 | 71,724,607 ( 76.46 %) | 0 | 76.46 % |
Company contact information
Neuropathix, Inc.
Pennsylvania Biotechnology Center 3805 Old Easton Road
18902, Doylestown
+
http://www.neuropathix.comSector
1st Jan change | Capi. | |
---|---|---|
-1.76% | 102B | |
+2.19% | 96.09B | |
+2.13% | 22.28B | |
-16.81% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-14.02% | 16.09B | |
+5.26% | 13.83B | |
+33.14% | 11.97B |